11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
In this third installment of our series, we will discuss the new details provided to taxpayers regar...
Read More >
Welcome to the June edition of the Alston & Bird CPSC Recall Snapshot. In May, the CPSC held its pu...
Read More >
On August 1, 2019, just a day prior to his resignation as Governor of Puerto Rico, Ricardo Rosselló ...
Read More >
1. Product Safety - 1.1 Legal Framework - The main laws and regulations governing product safety i...
Read More >
Designing an internal whistleblowing system - The issue of whistleblowing is drawing more and more...
Read More >
California is known for new employment laws that then trickle out to the east coast, the northwest, ...
Read More >